NTRB — Nutriband

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporat...

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Industry

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

Sector

Healthcare

Exchange

NASD

First trade date

2017-06-20

The interactive platform loads with JavaScript. Research tools are for informational purposes.